L avocat Kamagra oral jelly apotheke kaufen se retourne contre l assureur du fabricant. L Viagra receptfritt pa apoteket atelier a lieu tous les quinze jours. Je l Achat viagra sans ordonnance pharmacie ai arrêtée. Je craignais Viagra apotheke europa d être trop émue, dit-elle. Passer un Cialis generika billig kaufen deuxième, puis un troisième sas grillagé. Il Peut acheter viagra sans ordonnance s explique au Monde. Les Donde puedo comprar cialis monterrey malades peuvent reprendre le traitement , a dit M. On Quel est le prix d'une boite de viagra peut grandir en vieillissant. Libres Viagra kaufen deutsche apotheke aussi de changer. Tous, Comprar viagra contrareembolso en barcelona absolument tous, ont accepté. Projet Ou acheter du vrai kamagra non repris par la gauche. Il Comprar levitra generico en espana veut tout le temps qu on lui donne des somnifères. Ce qui Se vende la viagra sin receta revient à plus de 8 fois le tarif Sécu . J Cialis billigt sverige ai eu l impression de repartir des années en arrière. de Comprar vardenafil levitra remède anti-rhume. L Ou acheter viagra a montreal ANSM a pris acte de l arbitrage de Bruxelles. Il Comprar cialis murcia s agit de dire s il y a eu contamination. Tu Comprar cialis generico espana contrareembolso n as rien à craindre , a-t-elle dit au docteur. Sauvé, Achat viagra sans ordonnance pharmacie vice-président du Conseil d Etat.

Events

September – November 2015

Sep
17
Thu
FRAMEWORKS WORKSHOP: BASICS OF OBTAINING COMMERCIALLY EFFECTIVE IP @ Pillsbury Office, San Diego North County
Sep 17 @ 8:00 am – 12:30 pm
PROGRAM OVERVIEW:

Intellectual property rights are often key to the foundation, growth and ultimate survival of a company. For technology and bio-science companies, the ability to raise funding is dependent on establishing a sound intellectual property portfolio and strategy.

This program will give you a basic understanding of IP with emphasis on innovation protection using the patent system and trade secrets. It will also cover the legal requirements and basic process for obtaining a patent and the effect of recent major changes to the U.S. patent system.

8:00-11:30am: Presentation
11:30am-12:30pm: Optional lunch and discussion
Light breakfast and lunch are included for all attendees
WHAT YOU WILL LEARN:
  • The role of intellectual property in the deal
  • Business transactions where patents are a significant factor
  • Issues of importance to potential investors
  • Key licensing provisions to consider when exploiting the patent portfolio
WHO SHOULD ATTEND:

This workshop is reserved for Founders, CEO’s, Entrepreneurs, Managers, Researchers, VCs, Business Development Professionals, and Scientists, ONLY. Please, no competing law firms or private competitors.

ABOUT THE PRESENTER:

John Wetherell, J.D., PhD. has over 25 years’ experience in intellectual property law. His counseling experience includes intellectual property acquisition, transactional due diligence, patent infringement and validity analyses, freedom-to-operate opinions, as well as licensing and strategic counseling. Dr. Wetherell’s patent prosecution experience includes obtaining U.S. and foreign protection in biotechnology areas such as molecular biology, immunology, nanotechnology, medical diagnostics, microbiology and pharmacology. He also evaluates intellectual property portfolios for both companies and investors.

At Pillsbury, Dr. Wetherell is the partner in charge of the Intellectual Property practice group in the San Diego office, co-leader of the National Life Science industry group, leader of the Stem Cell Outlook and Planning Effort (SCOPE), and a member of the Clean Technology Group.

Sep
24
Thu
FRAMEWORKS WORKSHOP: MERGERS & ACQUISITIONS @ CONNECT Office
Sep 24 @ 8:00 am – 11:30 am
PROGRAM OVERVIEW:

While the economy continues to rebound, there still seems to be endless regulatory and fiscal changes and challenges when acquiring or selling a company.  In order to successfully navigate an M&A transaction in this evolving economic environment, it is critical that buyers and sellers understand what will be required to be successful in their strategic transaction efforts.

WHAT YOU WILL LEARN:
  • How companies are obtaining financing in today’s market
  • How to properly conduct due diligence from a buyer’s and seller’s perspective
  • Current landscape of the M&A market (valuations, financing alternatives and deal trends)
  • How to address a variety of confidentiality concerns in an M&A transaction
  • How making operational, financial and legal decisions can help your company maintain its value and remain an attractive partner through the sale process
  • How operating efficiency, customer/supplier quality, strategic focus, key management effectiveness and other non-financial metrics affect valuations and deal terms
  • How to plan and implement a successful post-acquisition integration strategy

 

WHO SHOULD ATTEND:

Anyone on either the buy and sell side who is preparing to engage in a potential merger, sale or acquisition or who wants to have a clear acquisition or disposition strategy in place.

 

ABOUT THE PRESENTERS:

Joe Davidson is the firm-wide Director of the Corporate & Finance Department at Allen Matkins, resident in the firm’s San Diego office.  Since 1979, Joe has advised and represented a broad variety of companies and entrepreneurs in both thriving and distressed economic environments in corporate and securities matters, mergers and acquisitions, public and private securities offerings, joint ventures, and strategic partnerships.

Clark Libenson is a corporate partner in the San Diego office of Allen Matkins, where his practice focuses on corporate finance and business transactions.  Clark services clients’ needs in public offerings and private placements of equity and debt, real estate securities, corporate reorganizations, mergers and acquisitions, employee equity and compensation arrangements, corporate governance, and board advisory matters.

Oct
1
Thu
FRAMEWORKS WORKSHOP: ESTABLISHING AN EFFECTIVE BIOSCIENCE IP PORTFOLIO @ Pillsbury Office, San Diego North County
Oct 1 @ 8:00 am – 12:30 pm
PROGRAM OVERVIEW

Bioscience companies rely more heavily on having an effective intellectual property portfolio than do companies based on other technologies. This workshop will cover basic elements involved in developing a commercially meaningful intellectual property portfolio for a bioscience company. Topics that will be discussed include identifying and protecting bioscience inventions, as well as decision making in developing, managing and investing in the portfolio.

8:00-11:30am: Presentation
11:30am-12:30pm: Optional lunch and discussion
Light breakfast and lunch are included for all attendees
WHAT YOU WILL LEARN
  • Effects of recent court decisions on the patentability of genetic material and diagnostic techniques
  • How to identify protectable bio-science inventions
  • The types of hurdles that must be cleared in obtaining meaningful patent protection
  • Strategic use of intellectual property
  • Bio-similars
  • Generic competition
WHO SHOULD ATTEND

This workshop is reserved for Founders, CEO’s, Entrepreneurs, Managers, Researchers, VCs, Business Development Professionals, and Scientists, ONLY. Please, no competing law firms or private competitors.

ABOUT THE PRESENTER

John Wetherell, J.D., PhD. has over 25 years’ experience in intellectual property law. His counseling experience includes intellectual property acquisition, transactional due diligence, patent infringement and validity analyses, freedom-to-operate opinions, as well as licensing and strategic counseling. Dr. Wetherell’s patent prosecution experience includes obtaining U.S. and foreign protection in biotechnology areas such as molecular biology, immunology, nanotechnology, medical diagnostics, microbiology and pharmacology. He also evaluates intellectual property portfolios for both companies and investors.

At Pillsbury, Dr. Wetherell is the partner in charge of the Intellectual Property practice group in the San Diego office, co-leader of the National Life Science industry group, leader of the Stem Cell Outlook and Planning Effort (SCOPE), and a member of the Clean Technology Group.

Oct
29
Thu
CONNECT NEW OFFICE OPENING & DEMO DAY EXTRAVAGANZA! @ CONNECT Office
Oct 29 @ 4:30 pm – 8:00 pm

Celebrate our slate of recent Springboard grads and see the new digs at this fun, Halloween-themed event! Combining the best of an open house and demo day, you’ll get the insider’s tour of CONNECT’s new space; the opportunity to meet the incredible companies that just graduated from CONNECT’s Springboard program, and a chance to chat with our CEO, Greg McKee, about what CONNECT is up to.

The night will kick-off to Halloween weekend in style with fun food trucks, plenty of drinks, and maybe a few surprises! Join us!

DEMO COMPANIES TO BE ANNOUNCED SOON!
Nov
12
Thu
FRAMEWORKS WORKSHOPS: BUSINESS ASPECTS OF PATENTS @ Pillsbury Office, San Diego North County
Nov 12 @ 8:00 am – 12:30 pm
PROGRAM OVERVIEW:

Intellectual property plays a seminal role in the success of many companies. While adequately protecting innovation is a major economic driver, as with any valuable asset, if it is not properly managed its full potential will not be realized and the company will fail. This program will focus on the role key business factors play in capturing, managing, and exploiting the intellectual property of the company.

8:00-11:30am: Presentation

11:30am-12:30pm: Optional lunch and discussion

Light breakfast and lunch are included for all attendees

WHAT YOU WILL LEARN:
  • The role of intellectual property in the deal
  • Business transactions where patents are a significant factor
  • Issues of importance to potential investors
  • Key licensing provisions to consider when exploiting the patent portfolio
WHO SHOULD ATTEND:

This workshop is reserved for Founders, CEO’s, Entrepreneurs, Managers, Researchers, VCs, Business Development Professionals, and Scientists, ONLY. Please, no competing law firms or private competitors.

ABOUT THE PRESENTER:

John Wetherell, J.D., PhD. has over 25 years’ experience in intellectual property law. His counseling experience includes intellectual property acquisition, transactional due diligence, patent infringement and validity analyses, freedom-to-operate opinions, as well as licensing and strategic counseling. Dr. Wetherell’s patent prosecution experience includes obtaining U.S. and foreign protection in biotechnology areas such as molecular biology, immunology, nanotechnology, medical diagnostics, microbiology and pharmacology. He also evaluates intellectual property portfolios for both companies and investors.

At Pillsbury, Dr. Wetherell is the partner in charge of the Intellectual Property practice group in the San Diego office, co-leader of the National Life Science industry group, leader of the Stem Cell Outlook and Planning Effort (SCOPE), and a member of the Clean Technology Group.